Related Concept Videos
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Diabetes Mellitus: Introduction
24
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Complications of Diabetes Mellitus
35
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
35
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
New program helps pharmacists give better patient care with lab tests.
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2014
Same author
Energize your pharmacy practice.
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2014
Same author
An educator in a pharmacist's coat: Donna Woloschuk.
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2013
Same author
Appendix a: management committee terms of reference.
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2013
Same author
Designing a novel continuing education program for pharmacists: Lessons learned.
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2013
Same journal
AFPC SHARP 2025 abstracts - oral and poster presentations.
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2025
Same journal
AFPC CPERC 2025 Abstracts - Oral and Poster Presentations.
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2025
Same journal
Pharmacists' experience with automated external defibrillators.
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2025
Same journal
Should all pharmacies have an automated external defibrillator?
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2025
Same journal
The landscape of automated external defibrillators in pharmacies: a preliminary survey.
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2025
Same journal
StaffWISE project Part 2: Exploring pharmacy practice environment issues in Nova Scotia.
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2025


